Physician profile
Vijai J Daniel
NPI 1043473986
$471,052.13
in general payments reported to CMS, 2019-2025
43 companies · $46K in 2025
The $46K reported for 2025 was more than what 97% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59K · 2020: $64K · 2021: $24K · 2022: $71K · 2023: $113K · 2024: $95K · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $208K · Travel and Lodging: $35K · Food and Beverage: $9,422 · Education: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $208,210.00 |
| Travel and Lodging | $34,977.67 |
| Food and Beverage | $9,421.72 |
| Education | $344.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $426,780.79 | 2019-2025 | Arexvy, Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $37,273.10 | 2019-2025 | Breztri, Tezspire, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $618.31 | 2019-2025 | Ofev, Jascayd |
| Actelion Pharmaceuticals US, INC. | $529.90 | 2019-2024 | Uptravi, Opsumit |
| Philips North America LLC | $506.00 | 2019-2025 | Vest Therapy Und, (8874) Incourage |
| Merck Sharp & Dohme LLC | $461.67 | 2020-2025 | Winrevair, Zerbaxa, Recarbrio |
| Harmony Biosciences LLC | $359.90 | 2021-2024 | Wakix |
| Astellas Pharma US INC | $352.14 | 2023-2024 | Cresemba |
| Regeneron Healthcare Solutions, INC. | $333.42 | 2019-2025 | Dupixent |
| Electromed, INC. | $297.33 | 2021-2025 | Smartvest |
| Insmed, INC. | $273.92 | 2019-2025 | Arikayce |
| Genentech USA, INC. | $266.06 | 2019-2021 | |
| Baxter Healthcare | $253.87 | 2022-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Grifols USA, LLC | $224.58 | 2019-2025 | Prolastin-C Liquid |
| United Therapeutics Corporation | $206.78 | 2019-2025 | Tyvaso, Tyvaso |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $206.40 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $203.57 | 2019-2020 | |
| Resmed Corp | $187.05 | 2019-2021 | |
| Verona Pharma, INC. | $186.93 | 2025 | Ohtuvayre |
| Allergan, INC. | $185.65 | 2019-2020 | |
| Abbvie INC. | $164.63 | 2021-2022 | |
| Mylan Specialty L.P. | $145.88 | 2019-2024 | Yupelri |
| Mallinckrodt Hospital Products INC. | $142.01 | 2021-2022 | |
| Genzyme Corporation | $116.77 | 2023-2025 | |
| Fisher & Paykel Healthcare INC | $94.34 | 2019-2024 | Fisher & Paykel Healthcare |
| E.R. Squibb & Sons, L.L.C. | $90.52 | 2022 | |
| Pulmonx Corporation | $75.30 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Janssen Pharmaceuticals, INC | $60.60 | 2022 | |
| Gilead Sciences, INC. | $52.59 | 2019-2025 | Veklury |
| Bayer Healthcare Pharmaceuticals INC. | $49.57 | 2019-2022 | |
| Circassia INC. | $47.54 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $46.35 | 2024-2025 | Nuzyra |
| Amgen INC. | $42.02 | 2022-2025 | Tavneos, Tezspire |
| Ani Pharmaceuticals, INC. | $37.14 | 2023 | Purified Cortrophin Gel |
| Teva Pharmaceuticals USA, INC. | $36.75 | 2019-2022 | |
| Ceribell, INC. | $32.39 | 2020-2021 | |
| Inspire Medical Systems, INC. | $17.84 | 2023 | Inspire |
| Shire North American Group INC | $16.62 | 2019 | |
| Vifor Pharma, INC. | $16.42 | 2024 | Zemaira |
| Takeda Pharmaceuticals U.S.A., INC. | $16.29 | 2020 | |
| Ambu INC. | $15.83 | 2020 | |
| Medtronic, INC. | $13.95 | 2021 | |
| Pfizer INC. | $13.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijai Daniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.